
ChemPass is a drug discovery company based in Hungary that leverages AI-assisted design methods to optimize lead discovery processes. Their AID platform significantly reduces the time and cost associated with lead optimization while expanding patentable intellectual property. With a focus on medicinal chemistry and library design, ChemPass offers a unique combination of services that cater to both large pharmaceutical companies and smaller biotech firms, positioning itself as a leader in the chemoinformatics space.

ChemPass is a drug discovery company based in Hungary that leverages AI-assisted design methods to optimize lead discovery processes. Their AID platform significantly reduces the time and cost associated with lead optimization while expanding patentable intellectual property. With a focus on medicinal chemistry and library design, ChemPass offers a unique combination of services that cater to both large pharmaceutical companies and smaller biotech firms, positioning itself as a leader in the chemoinformatics space.
Headquarters: Budapest, Hungary
Founded: 2016
Core product: AI-assisted platform for small-molecule design and lead optimization
Notable investor: Hiventures
Drug discovery — medicinal chemistry, lead optimization, and library design
2016
Biotechnology
459,929 USD
“Hiventures participation in disclosed seed rounds”